Researchers have been excited about this new drug, a novel dual agonist showing promising data in clinical trials for weight loss . It acts by modulating both systems: GLP-1 and GIP, that , when https://mariamavwr167358.blogdomago.com/39346583/this-new-possibility-for-size-loss